Vir Biotechnology (VIR, $8.75) was one of the top gainers this week, climbing to $8.75 per share. A.I.dvisor analyzed 915 stocks in the Biotechnology Industry over the last week and discovered that of them (7) trended up while of them (2) trended down.
a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases